Clinical Trial Update: Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating radiation therapy with or without bicalutamide for recurrent pT3N0 prostate cancer after radical prostatectomy; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Radiation therapy
• bicalutamide (bicalutamide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-08-18